Jeff Wiezorek
About Jeff Wiezorek
Jeff Wiezorek serves as the Global Head of Cell Therapy Development at Kite Pharma, a position he has held since 2018. He earned his MD from Columbia University Vagelos College of Physicians and Surgeons and has extensive experience in the pharmaceutical industry, including roles at Amgen and Kite Pharma.
Current Role at Kite Pharma
Jeff Wiezorek serves as the Global Head of Cell Therapy Development at Kite Pharma. He has held this position since 2018, overseeing the development of innovative cell therapies. His role involves strategic leadership in clinical development and ensuring the advancement of Kite's therapeutic pipeline. Based in Santa Monica, CA, he contributes to the company's mission of transforming cancer treatment through cutting-edge cell therapy solutions.
Previous Experience at Kite Pharma
Prior to his current role, Jeff Wiezorek worked at Kite Pharma as the Senior Vice President of Clinical Development from 2014 to 2018. During this time, he played a significant role in the clinical advancement of Kite's cell therapy products. His experience at Kite laid the groundwork for his current responsibilities and leadership in cell therapy development.
Experience at Amgen
Jeff Wiezorek worked at Amgen as the Executive Medical Director of Global Development from 2004 to 2014. In this capacity, he was involved in various aspects of drug development, contributing to Amgen's portfolio of therapies. His decade-long tenure at Amgen provided him with extensive experience in the biotechnology sector.
Education and Expertise
Jeff Wiezorek earned his MD from Columbia University Vagelos College of Physicians and Surgeons. He also studied at Caltech, which contributed to his strong foundation in the sciences. His educational background supports his expertise in clinical development and cell therapy.